ARCHIVES

NCAB Opposes Line Item for Centers

This article is from The Cancer Letter archive.

Vol. 06 No. 21 | May 23, 1980

Download PDF Visit The Full Archive

Related Articles

FDA Approves Lilly’s Alimta For Metastatic NSCLC

August 27, 2004

Hyperthermia, Radiation Enhancement, New Drugs Offer More Therapy Advances, ASCO Members Hear

April 7, 1978

Gene Expression Data Posted On Web For Research Use.

March 17, 2000

ASCO Recommends Against Routine Adjuvant Chemo For Stage II Colon Cancer

August 27, 2004

Barret’s Less of a Risk Factor For Cancer of the Esophagus

June 24, 2011

NCI Raises R01 Payline To 16th Percentile FY09. Coalition Formed To Advocate For Medical Innovation

March 27, 2009